Decline in share prices of securities held
First written in FY2016. 2 of 24 entries say "Restated". Latest entry: 2026-10-02.
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
0 other companies' latest entry also says "Cited as achieved".
- 2026-10-02Cited as achievedfinance.yahoo.co.jp
「Net income rose 73.4% to ¥2.7 billion, supported by gains on the sale of cross-held shares.」
It was reported that gains on the sale of cross-held shares contributed to the increase in net income in the first quarter. - FY2026Gains on sales of securities and recognition of valuation lossesAnnual report
「Proceeds of ¥1,475 million from the sale of investment securities, a ¥1,056 million gain on sale of investment securities, and a ¥99 million loss on valuation of investment securities were recognized.」
Regarding changes in assets held, the company disclosed proceeds and gains from the sale of investment securities and the recognition of valuation losses. - FY2025Gains on sales of securities and recognition of valuation lossesAnnual report
「A ¥2,049 million gain on sale of investment securities, a ¥6 million loss on sale of investment securities, and a ¥94 million loss on valuation of investment securities were recognized.」
Regarding changes in the value of assets held, gains and losses on the sale of investment securities and a ¥94 million loss on valuation were recognized. The valuation difference on other securities decreased by ¥2,786 million from the end of the previous fiscal year. - FY2025-H1Decrease in valuation difference and recognition of gains and losses on sales of securitiesAnnual report
「Net assets increased by ¥1,876 million due to interim net income attributable to owners of the parent, decreased by ¥1,599 million due to dividend payments, decreased by ¥194 million due to the valuation difference on other securities, and increased by ¥534 million due to foreign currency translation adjustments, among other factors. As a result, net assets increased by ¥907 million from the end of the previous consolidated fiscal year to ¥66,502 million.」
Unlike in the same period of the previous year, the valuation difference on other securities decreased by ¥194 million. The interim income statement reported a ¥39 million gain on sale of investment securities and a ¥6 million loss on sale. The text does not indicate a direct causal relationship between the decrease in the valuation difference and stock market conditions. - FY2024Increase in valuation difference and recognition of gain on sale of securitiesAnnual report
「The valuation difference on other securities increased by ¥3,320 million, and a ¥505 million gain on sale of investment securities was recognized.」
Regarding changes in the value of assets held, the valuation difference on other securities increased from ¥8,950 million at the end of the previous fiscal year to ¥12,271 million, and a ¥505 million gain on sale of investment securities was recognized. - FY2024-Q3Increase in valuation difference and recognition of gain on sale of securitiesAnnual report
「The valuation difference on other securities increased by ¥936 million, among other factors, resulting in an increase of ¥2,020 million from the end of the previous consolidated fiscal year to ¥60,233 million. Gain on sale of investment securities － 505」
The valuation difference on other securities increased by ¥936 million from the end of the previous consolidated fiscal year, and a ¥505 million gain on sale of investment securities was recognized during the cumulative third-quarter period. The text does not indicate a direct causal relationship between the increase in the valuation difference and stock market conditions. - FY2024-Q2Increase in valuation differencesAnnual report
「The valuation difference on other securities increased by ¥1,060 million, among other factors, resulting in a decrease of ¥200 million from the end of the previous consolidated fiscal year to ¥58,012 million.」
The valuation difference on other securities increased by ¥1,060 million from the end of the previous consolidated fiscal year to ¥100,100 million. The text does not indicate a direct causal relationship with the decline in stock market conditions. - FY2024-Q1Increase in valuation differencesAnnual report
「Net assets increased by ¥489 million due to net income attributable to owners of the parent, decreased by ¥1,401 million due to dividend payments, and increased by ¥1,006 million due to the valuation difference on other securities, among other factors. As a result, net assets increased by ¥260 million from the previous consolidated fiscal year to ¥58,473 million.」
The valuation difference on other securities increased by ¥1,006 million from the end of the previous consolidated fiscal year. The text does not indicate a direct causal relationship between the increase and stock market conditions. - FY2023-Q3Increase in Valuation Difference and Recognition of Valuation LossAnnual report
「Valuation difference on other securities 8,477 8,696 Loss on valuation of investment securities － 21」
The valuation difference on other securities increased from ¥8,477 million at the end of the previous consolidated fiscal year to ¥8,696 million, and a ¥21 million loss on valuation of investment securities was recognized during the cumulative third-quarter period. - FY2023-Q2Increase in Valuation Difference and Recognition of Valuation LossAnnual report
「The valuation difference on other securities increased by ¥1,456 million, resulting in an increase of ¥2,262 million from the end of the previous consolidated fiscal year to ¥56,075 million. Loss on valuation of investment securities 21」
The valuation difference on other securities increased by ¥1,456 million, and a ¥21 million loss on valuation of investment securities was recognized during the cumulative second-quarter period. - FY2023-Q1Increase in valuation differencesAnnual report
「Net assets increased by ¥682 million due to quarterly net income attributable to owners of the parent, decreased by ¥1,282 million due to dividend payments, and increased by ¥1,292 million due to the valuation difference on other securities, among other factors. As a result, net assets increased by ¥656 million from the previous consolidated fiscal year to ¥54,469 million.」
The valuation difference on other securities increased by ¥1,292 million from the end of the previous consolidated fiscal year. The text does not indicate a direct causal relationship between the increase and stock market conditions. - FY2022-Q3Decrease in valuation difference and recognition of gains and losses on sales of securitiesAnnual report
「Investment securities 23,006 22,626 Valuation difference on other securities 9,535 9,331 Gain on sales of investment securities － 4 Loss on sales of investment securities － 12」
At the end of the third quarter, investment securities stood at ¥22,626 million and the valuation difference on other securities at ¥9,331 million. In addition, a gain on sales of investment securities of ¥4 million and a loss on sales of investment securities of ¥12 million were recognized. - FY2022-Q2Increase in valuation difference and recognition of gains and losses on sales of securitiesAnnual report
「The valuation difference on other securities increased by ¥132 million, among other factors, resulting in an increase of ¥1,045 million from the end of the previous consolidated fiscal year to ¥51,749 million.」
The valuation difference on other securities increased by ¥132 million from the end of the previous consolidated fiscal year. In addition, a gain on sales of investment securities of ¥4 million and a loss on sales of investment securities of ¥12 million were recognized. - FY2022-Q1Decrease in Valuation DifferenceAnnual report
「The valuation difference on other securities decreased by ¥536 million, among other factors, resulting in a decrease of ¥273 million from the previous consolidated fiscal year to ¥50,430 million.」
The valuation difference on other securities decreased by ¥536 million from the end of the previous consolidated fiscal year. No impairment loss on investment securities was recognized during the first quarter. - FY2021ReframedAnnual report
「If the value of securities and other assets held by the Group declines substantially, the resulting valuation losses may have a material impact on the Group’s financial position, operating results and other aspects of its business.」
The previous risk of declines in share prices has been reorganized to include fluctuations in the value of securities and other assets held and the impact of valuation losses on the Group’s financial position and operating results. - FY2021-Q3Increase in Valuation Difference and Recognition of Valuation LossAnnual report
「The valuation difference on other securities increased by ¥2,076 million, among other factors, resulting in an increase of ¥3,120 million from the previous consolidated fiscal year to ¥47,522 million. Impairment loss on investment securities: 5」
The valuation difference on other securities increased by ¥2,076 million, while an impairment loss on investment securities of ¥5 million was recognized during the first nine months. - FY2021-Q2Increase in valuation differences, with no valuation lossAnnual report
「Net assets increased by ¥1,214 million due to quarterly net income attributable to owners of the parent, decreased by ¥1,160 million due to dividend payments, and increased by ¥1,461 million due to the valuation difference on other securities, among other factors. As a result, net assets increased by ¥1,459 million from the previous consolidated fiscal year to ¥45,862 million.」
The valuation difference on other securities increased by ¥1,461 million year on year. No impairment loss on investment securities was recognized in the first six months in the quarterly consolidated income statement. - FY2021-Q1Increase in Valuation Difference and Recognition of Valuation LossAnnual report
「The valuation difference on other securities increased by ¥1,583 million, among other factors, resulting in an increase of ¥592 million from the previous consolidated fiscal year to ¥44,995 million. Impairment loss on investment securities: 7」
The valuation difference on other securities increased by ¥1,583 million, while an impairment loss on investment securities of ¥7 million was recognized during the first quarter. The description does not indicate a direct causal relationship with declines in share prices. - FY2020MaterialisedAnnual report
「The main components of extraordinary income and losses for the current consolidated fiscal year were a gain on sales of investment securities of ¥240 million and an impairment loss on investment securities of ¥353 million.」
With respect to the risk of changes in the value of securities held, the company recognized an impairment loss on investment securities of ¥353 million during the fiscal year. - FY2020-Q3Increase in Valuation Difference and Recognition of Valuation LossAnnual report
「The valuation difference on other securities increased by ¥527 million, among other factors, resulting in an increase of ¥860 million from the previous consolidated fiscal year to ¥43,925 million. Impairment loss on investment securities: 104」
The valuation difference on other securities increased by ¥527 million year on year, while an impairment loss on investment securities of ¥104 million was recognized during the first nine months. The description does not indicate a direct causal relationship with declines in share prices. - FY2020-Q2Decrease in valuation difference and recognition of valuation lossesAnnual report
「The valuation difference on other securities decreased by ¥504 million, among other factors, resulting in a decrease of ¥327 million from the previous consolidated fiscal year to ¥42,737 million. Impairment loss on investment securities: 113」
The decrease in the valuation difference on other securities and an impairment loss on investment securities of ¥113 million are disclosed. The description does not indicate a direct causal relationship with declines in share prices. - FY2018RestatedAnnual report
「The Group’s business performance may be affected by declines in share prices of securities held by the Group.」
The risk of declines in the market prices of shares held continues to be described. - FY2017RestatedAnnual report
「The Group’s business performance may be affected by declines in share prices of securities held by the Group.」
The risk of declines in the share prices of securities held continues to be described. - FY2016First statedAnnual report
「The Group’s business performance may be affected by declines in share prices of securities held by the Group.」
The impact on business performance of declines in the market prices of securities held is described.